We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-13.18%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$86.6M
AUM Growth
-$19M
Cap. Flow
-$7.16M
Cap. Flow %
-8.26%
Top 10 Hldgs %
77.71%
Holding
93
New
35
Increased
1
Reduced
9
Closed
28

Top Buys

Rank Stock Value
1
SCOR icon
Comscore
SCOR
+$29.2M
2
CARM
Carisma Therapeutics
CARM
+$12.1M
3
EMWP
Eros Media World PLC
EMWP
+$10.8M
4
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$5.04M
5
CALA
Calithera Biosciences, Inc
CALA
+$4.79M

Top Sells

Rank Stock Value
1
NSTG
NanoString Technologies, Inc.
NSTG
+$18.5M
2
BPMC
Blueprint Medicines
BPMC
+$16M
3
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$8.16M
4
GNFT
Genfit
GNFT
+$6.12M
5
SYRE icon
Spyre Therapeutics
SYRE
+$2.19M

Sector Composition

Rank Sector Weight
1 Healthcare 32.81%
2 Technology 16.82%
3 Consumer Staples 4.12%
4 Communication Services 3.85%
5 Industrials 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCOR icon
1
Comscore
SCOR
$112M
$14.1M 16.25%
+136,426
New +$29.2M
CARM
2
DELISTED
Carisma Therapeutics
CARM
$12.2M 14.05%
+405,644
New +$12.1M
MDCO
3
DELISTED
Medicines Co
MDCO
$4.12M 4.75%
+112,950
New +$3.69M
SRNE
4
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$3.74M 4.32%
+1,401,640
New +$5.04M
CALA
5
DELISTED
Calithera Biosciences, Inc
CALA
$3.29M 3.8%
+42,162
New +$4.79M
EMWP
6
DELISTED
Eros Media World PLC
EMWP
$2.83M 3.27%
104,930
+79,985
+321% +$10.8M
GNFT
7
DELISTED
Genfit
GNFT
$2.73M 3.15%
138,185
-261,815
-65% -$6.12M
SRRK icon
8
Scholar Rock
SRRK
$5.7B
$2.65M 3.06%
+167,371
New +$3.1M
LAUR icon
9
Laureate Education
LAUR
$5.27B
$1.91M 2.21%
+121,792
New +$1.94M
ORTX
10
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.83M 2.11%
+13,065
New +$2.29M
KURA icon
11
Kura Oncology
KURA
$796M
$1.2M 1.38%
+60,800
New +$1.01M
NTBL
12
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$1.18M 1.36%
25,965
-5,293
-17% -$241K
AIHS icon
13
Senmiao Technology Ltd
AIHS
$20.5M
$1.11M 1.28%
+3,983
New +$1.74M
AQB icon
14
AquaBounty Technologies
AQB
$4.59M
$1.06M 1.22%
+17,260
New +$814K
CYCN icon
15
Cyclerion Therapeutics
CYCN
$15.1M
$899K 1.04%
+3,928
New +$1.11M
TBIO
16
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$852K 0.98%
+67,464
New +$711K
EYPT icon
17
EyePoint Inc
EYPT
$1.03B
$748K 0.86%
45,581
-102,890
-69% -$1.73M
ELOX
18
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$742K 0.86%
+1,860
New +$783K
MCRB icon
19
Seres Therapeutics
MCRB
$45.6M
$727K 0.84%
+11,290
New +$1.07M
RGLS
20
DELISTED
Regulus Therapeutics
RGLS
$568K 0.66%
+45,419
New +$523K
CHRN
21
ChronoScale Holdings
CHRN
$3.27B
$494K 0.57%
+1,727
New +$714K
CTHR
22
DELISTED
Charles & Colvard Ltd
CTHR
$452K 0.52%
+28,585
New +$433K
RKDA icon
23
Arcadia Biosciences
RKDA
$1.38M
$414K 0.48%
+3,377
New +$718K
INSM icon
24
Insmed
INSM
$21.2B
$374K 0.43%
+14,627
New +$407K
ZYME icon
25
Zymeworks
ZYME
$1.62B
$373K 0.43%
+16,956
New +$311K
1
2 3 4

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q2 2019 Portfolio in Review

As of Q2 2019, CVI Holdings held 93 positions worth $86.6M, down 18% from $106M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

CVI Holdings withdrew a net $7.16M in Q2 2019, closing 28 positions and reducing 9 holdings. Its most notable exit was NanoString Technologies, Inc., an estimated $18.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 68% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, CVI Holdings opened a new position in Comscore worth $14.1M.

  • CVI Holdings's largest Q2 2019 buy was Comscore: 136,426 shares worth $14.1M.
  • CVI Holdings added most to Eros Media World PLC in Q2 2019, an estimated $10.8M increase.
  • CVI Holdings's biggest Q2 2019 reduction was Genfit, cutting an estimated $6.12M.
  • CVI Holdings fully exited NanoString Technologies, Inc. in Q2 2019, selling an estimated $18.5M.
  • CVI Holdings's ten largest holdings make up 78% of its $86.6M portfolio in Q2 2019.
  • CVI Holdings opened 35 new positions and closed 28 in Q2 2019.
  • CVI Holdings's portfolio value fell 18% quarter-over-quarter to $86.6M.

Based on CVI Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.